Search Results - Ruby John Anto
- Showing 1 - 9 results of 9
-
1
-
2
Editorial: The use of plant metabolites to ameliorate sequelae of chemotherapy by Cijo George Vazhappilly, Shoib Sarwar Siddiqui, Ruby John Anto, Ruby John Anto, Rajan Radhakrishnan, Naveen Kumar Devanga Ragupathi, Naveen Kumar Devanga Ragupathi
Published in Frontiers in Pharmacology (2023-11-01)Get full text
Article -
3
-
4
Editorial: Role of extracellular vesicles (EVs) in pathogenesis, diagnosis, therapeutic delivery, treatment and theranostic applications in cancer by Reza Shahbazi, Reza Shahbazi, Reza Shahbazi, Kalimuthu Kalishwaralal, Manash K. Paul, Manash K. Paul, Ruby John Anto
Published in Frontiers in Bioengineering and Biotechnology (2023-09-01)Get full text
Article -
5
Unlocking nature’s pharmacy: an in-depth exploration of phytochemicals as potential sources of anti-cancer and anti-inflammatory molecules by Shifana C. Sadiq, Maria Pellissery Joy, Sreekumar U. Aiswarya, Abhishek Ajmani, Chenicheri K. Keerthana, Tennyson P. Rayginia, Noah Isakov, Ruby John Anto
Published in Exploration of Drug Science (2024-10-01)Get full text
Article -
6
Corrigendum: Targeting thymidylate synthase enhances the chemosensitivity of triple-negative breast cancer towards 5-FU-based combinatorial therapy by Nair Hariprasad Haritha, Akbar Nawab, Vinod Vijayakurup, Nikhil Ponnoor Anto, Vijayasteltar B. Liju, Vijai V. Alex, Areekkara Nisthul Amrutha, Sreekumar U. Aiswarya, Mundanattu Swetha, Balachandran S. Vinod, Sankar Sundaram, Maria V. Guijarro, Thomas Herlevich, Archana Krishna, Nesteena K. Nestory, Smitha V. Bava, Chittalakkottu Sadasivan, Maria Zajac-Kaye, Ruby John Anto
Published in Frontiers in Oncology (2023-12-01)Get full text
Article -
7
Targeting Thymidylate Synthase Enhances the Chemosensitivity of Triple-Negative Breast Cancer Towards 5-FU-Based Combinatorial Therapy by Nair Hariprasad Haritha, Akbar Nawab, Vinod Vijayakurup, Nikhil Ponnoor Anto, Vijayasteltar B. Liju, Vijai V. Alex, Areekkara Nisthul Amrutha, Sreekumar U. Aiswarya, Mundanattu Swetha, Balachandran S. Vinod, Sankar Sundaram, Maria V. Guijarro, Thomas Herlevich, Archana Krishna, Nesteena K. Nestory, Smitha V. Bava, Chittalakkottu Sadasivan, Maria Zajac-Kaye, Ruby John Anto
Published in Frontiers in Oncology (2021-07-01)Get full text
Article -
8
Augmented Efficacy of Uttroside B over Sorafenib in a Murine Model of Human Hepatocellular Carcinoma by Mundanattu Swetha, Chenicheri K. Keerthana, Tennyson P. Rayginia, Lekshmi R. Nath, Nair Hariprasad Haritha, Anwar Shabna, Kalishwaralal Kalimuthu, Arun K. Thangarasu, Sreekumar U. Aiswarya, Somaraj Jannet, Sreekumar Pillai, Kuzhuvelil B. Harikumar, Sankar Sundaram, Nikhil Ponnoor Anto, Dee H. Wu, Ravi S. Lankalapalli, Rheal Towner, Noah Isakov, Sathyaseelan S. Deepa, Ruby John Anto
Published in Pharmaceuticals (2022-05-01)Get full text
Article -
9
Corrigendum: Cucurbitacin B, purified and characterized from the rhizome of Corallocarpus epigaeus exhibits anti-melanoma potential by Sreekumar Usha Devi Aiswarya, Sreekumar Usha Devi Aiswarya, Gowda Vikas, Nair Hariprasad Haritha, Vijayasteltar Belsamma Liju, Vijayasteltar Belsamma Liju, Anwar Shabna, Mundanattu Swetha, Tennyson Prakash Rayginia, Chenicheri Kizhakkeveettil Keerthana, Lekshmi Raghu Nath, Lekshmi Raghu Nath, Mullan Vellandy Reshma, Mullan Vellandy Reshma, Sankar Sundaram, Nikhil Ponnoor Anto, Ravi Shankar Lankalapalli, Ravi Shankar Lankalapalli, Ruby John Anto, Smitha Vadakkeveettil Bava
Published in Frontiers in Oncology (2022-08-01)Get full text
Article
